Literature DB >> 9167602

Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literature.

R E McLendon1, R C Bentley, J E Parisi, R D Tien, J C Harrison, N J Tarbell, A L Billitt, R J Gualtieri, H S Friedman.   

Abstract

OBJECTIVE: Malignant neoplasms exhibiting mixed populations of neuronal and glial cells occurring in the cerebral hemispheres of young adults and children are well recognized, but rare. A confusing array of diagnostic terms has arisen. We describe two patients with such tumors and review the literature concerning these interesting cases. PATIENTS: A 21-year-old man and a 5-year-old girl presented with large, cystic, intracerebral lesions on magnetic resonance images, which proved to be composite neoplasms exhibiting malignant neurons and astrocytes.
RESULTS: The 21-year-old man had a frontal lobe mass with enhancing and nonenhancing regions, which corresponded to cerebral neuroblastoma and anaplastic astrocytoma, respectively. The presence of occasional microtubules and rare primitive presynaptic processes, accompanied by antisynaptophysin immunoreactivity, established the neuronal nature of the cells in the enhancing region. The nonenhancing region was composed of a moderately cellular neoplasm of fibrillar astrocytes that were mitotically active. The 5-year-old girl presented with a left parietal lobe neoplasm, which histologically was composed of lobular proliferations of neuroblasts and glia. The neuroblastic populations exhibited evidence of maturation with small anaplastic cells, spindle-shaped cells, and large dysmorphic ganglion cells. The glial tumor showed both well-differentiated fibrillary astrocytes with microcysts and anaplastic populations with central necrosis and pseudopalisading.
CONCLUSIONS: Present classification systems devised to describe mixed neuronal and glial tumors do not adequately encompass the diversity of morphologies presented by these two cases. We conclude that the terms cerebral neuroblastoma-anaplastic astrocytoma for case 1 and cerebral ganglioneuroblastoma-glioblastoma for case 2 are preferred because they convey useful clinical information by reflecting concepts already encompassed by the World Health Organization's classification system of tumors of the central nervous system.

Entities:  

Mesh:

Year:  1997        PMID: 9167602

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.

Authors:  Xianyuan Song; R Andrew Allen; S Terence Dunn; Kar-Ming Fung; Peter Farmer; Shital Gandhi; Tulika Ranjan; Alexis Demopoulos; Marc Symons; Michael Schulder; Jian Yi Li
Journal:  Int J Clin Exp Pathol       Date:  2011-09-17

Review 2.  Central nervous system (CNS) neuroblastoma. A case-based update.

Authors:  Federico Bianchi; Gianpiero Tamburrini; Marco Gessi; Paolo Frassanito; Luca Massimi; Massimo Caldarelli
Journal:  Childs Nerv Syst       Date:  2018-03-08       Impact factor: 1.475

Review 3.  Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.

Authors:  Gang Li; Zhiguo Zhang; Jianghong Zhang; Tianbo Jin; Hongjuan Liang; Li Gong; Guangbin Cui; Haixia Yang; Shiming He; Yongsheng Zhang; Guodong Gao
Journal:  Diagn Pathol       Date:  2014-01-21       Impact factor: 2.644

4.  A Rare Manifestation of a Presumed Non-Osteophilic Brain Neoplasm: Extensive Axial Skeletal Metastases From Glioblastoma With Primitive Neuronal Components.

Authors:  Tianhua Rong; Wanjing Zou; Xiaoguang Qiu; Wei Cui; Duo Zhang; Bingxuan Wu; Zhuang Kang; Wenbin Li; Baoge Liu
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

5.  Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases.

Authors:  Hong Rye Kim; Jae Jun Lee; Jung-Il Lee; Do Hyun Nam; Yeon-Lim Suh; Ho Jun Seol
Journal:  J Korean Neurosurg Soc       Date:  2016-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.